New Drugs

Brand/Generic Company Description
Braftovi
encorafenib
Pfizer

A kinase inhibitor for unresectable or metastatic melanoma (used with binimetinib).

Brukinsa
zanubrutinib
BeiGene

Oral Bruton tyrosine kinase inhibitor for Waldenström’s macroglobulinemia.

Dojolvi
triheptanoin
Ultragenyx

Oral medium-chain triglyceride for long-chain fatty acid oxidation disorders.

Enhertu
trastuzumab deruxtecan
AstraZeneca

A monoclonal antibody for unresectable/metastatic HER2-positive breast cancer.

Evrysdi
risdiplam
Hoffmann-La Roche

An oral agent for spinal muscular atrophy.

Foclivia
pandemic influenza vaccine
Seqirus

An H5N1 flu vaccine for influenza prevention in officially declared pandemic situations.

Kesimpta
ofatumumab
Novartis

A monoclonal antibody for relapsing-remitting multiple sclerosis.

Mektovi
binimetinib
Pfizer

A kinase inhibitor for unresectable or metastatic melanoma (used with encorafenib).

Nexstellis
estetrol/drospirenone
Searchlight Pharma

A new combined oral contraceptive.

Phesgo
pertuzumab/trastuzumab
Hoffmann-La Roche

Monoclonal antibody fixed-dose combo for early and metastatic breast cancer.

Ponvory
ponesimod
Janssen

Oral sphingosine-1-phosphate receptor 1 modulator for relapsing remitting MS.

Riabni
rituximab
Amgen

A new biosimilar to Rituxan.

Supemtek
influenza vaccine
Sanofi Pasteur

A quadrivalent vaccine for prevention of influenza in adults.

Triferic Avnu
ferric pyrophosphate citrate
Rockwell Medical (US)/RMC Healthcare (CAN)

Intravenous iron replacement therapy to maintain hemoglobin in hemodialysis-dependent chronic kidney disease.

Vistaseal
fibrin sealant (human)
Grifols (SA)/J&J Medical

A topical hemostatic to improve hemostasis during surgery.

Vyepti
eptinezumab
Lundbeck

An injectable CGRP-binding antibody for migraine prevention in adults.

Brand/Generic Company Description
Bryhali
halobetasol
Bausch Health

New high/super-high potency 0.01% topical steroid lotion for dermatoses and plaque psoriasis.

Cequa
cyclosporine
Sun Pharma

New 0.09% ophthalmic solution for moderate/severe dry eye.

Inprosub
progesterone
IBSA (Switz)

New subcutaneous formulation for in vitro fertilization treatment.

Onureg
azacitidine
Celgene/BMSquibb

New oral formulation for maintenance therapy in adults with acute myeloid leukemia.

Vyxeos
cytarabine/ daunorubicin
Jazz Pharma

New combination antineoplastic liposomal formulation for certain types of acute myeloid leukemia.

Brand/Generic Company Description